Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
60
Frequently Asked Questions
What is Market Cap of Passage Bio Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Passage Bio Inc market cap is $22.37M.
What is the 52-week high for Passage Bio Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Passage Bio Inc 52 week high is $26.60 as of September 22, 2025.
What is the 52-week low for Passage Bio Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Passage Bio Inc 52 week low is $5.12 as of September 22, 2025.
What is Passage Bio Inc stock price today?
Passage Bio Inc stock price today is $7.17.
What was Passage Bio Inc stock price yesterday?
Passage Bio Inc stock price yesterday was $7.55.
What is the PE ratio of Passage Bio Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Passage Bio Inc’s P/E ratio is -0.39.
What is the Price-to-Book ratio of Passage Bio Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Passage Bio Inc P/B ratio is 0.5957.
What is the 50-day moving average of Passage Bio Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Passage Bio Inc 50-day moving average is $6.65.
